Loading
companiesCompany
SBI Pharmaceuticals
SBI Pharmaceuticals is the Tokyo company behind 5-aminolevulinic acid products in Japan, including Alaglio, which makes bladder tumours glow during cystoscopy so surgeons can see and remove them.
Also called: SBI ALApharma Canada, Inc.SBI ALApharmaSBIファーマ
Overview
SBI Pharmaceuticals, part of Japan's SBI group and founded in 2011, develops medicines and supplements based on 5-aminolevulinic acid. Its Alaglio was approved in Japan for photodynamic diagnosis of bladder cancer during transurethral resection and for glioma surgery, and its Canadian arm SBI ALApharma Canada ran phase 3 trials to bring the bladder cancer indication to North America, registered on ClinicalTrials.gov.
Headquarters
Tokyo, JP
Scorecard
All companies#175of 1244 companies, score 33
- approved products +6
- modalities +2
- regions +2
- registry trials +23
1 approved, 0 in phase 3, 0 earlier, 0 targets, 136 registry studies. Formula on the scorecards page.
Type
Stage
Large private
Website
Founded
2011
ApprovedTopical porphyrin precursor for photodynamic therapy
Aminolevulinic acid (topical, for photodynamic therapy) · Levulan Kerastick / Ameluz
Aminolevulinic acid is painted on sun-damaged skin and then activated with a lamp, destroying actinic keratoses before they can become skin cancer; in Europe the gel is also approved for superficial basal cell carcinoma.
Similar pages
- Companyphotonamic
Shares Aminolevulinic acid (topical, for photodynamic therapy), Fluorescence-guided surgery, Pivotal (registrational) trial, Clinical trial.
- CompanyKarl Storz
Shares Cystoscopy, blue-light imaging & TURBT, Fluorescence-guided surgery.
- CompanyBlaze Bioscience
Shares Fluorescence-guided surgery, Pivotal (registrational) trial, Clinical trial.
- CompanyDenovo Biopharma
Shares Pivotal (registrational) trial, Clinical trial, Glioma & glioblastoma.
- TrialA Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma
Shares Aminolevulinic acid (topical, for photodynamic therapy), Glioma & glioblastoma.
- TrialAdjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
Shares Aminolevulinic acid (topical, for photodynamic therapy), Glioma & glioblastoma.
- CompanyVasGene Therapeutics
Shares Pivotal (registrational) trial, Clinical trial, Bladder & urothelial cancer.
- CompanyDiffusion Pharmaceuticals
Shares Pivotal (registrational) trial, Clinical trial, Glioma & glioblastoma.
cancers
technologies
drugs
ApprovedTopical porphyrin precursor for photodynamic therapy
Aminolevulinic acid (topical, for photodynamic therapy) · Levulan Kerastick / Ameluz